Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02137 BRII-B > Detailed Quotes

02137 BRII-B

5.300
+0.080+1.53%
Closed 09/30 16:08 CCT
High
5.350
Open
5.220
Turnover
3.79M
Low
5.100
Pre Close
5.220
Volume
721.00K
Market Cap
3.83B
P/E(TTM)
Loss
52wk High
48.650
Shares
723.35M
P/E(Static)
Loss
52wk Low
5.100
Float Cap
3.83B
Bid/Ask %
22.50%
Historical High
52.600
Shs Float
723.35M
Volume Ratio
0.23
Historical Low
5.100
Dividend TTM
--
Div Yield TTM
--
P/B
1.02
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.10%
Amplitude
4.79%
Avg Price
5.255
Lot Size
500
Float Cap
3.83B
Bid/Ask %
22.50%
Historical High
52.600
Shs Float
723.35M
Volume Ratio
0.23
Historical Low
5.100
Dividend TTM
--
P/B
1.02
Dividend LFY
--
Turnover Ratio
0.10%
Amplitude
4.79%
Avg Price
5.255
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Tengsheng Boyao Biotechnology Co., Ltd. is a biotechnology company headquartered in China and the United States, mainly engaged in infectious disease therapy research and development business. The company's products are used in infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria infections) and other diseases with significant public health burdens, such as central nervous system (CNS) diseases. The company also develops treatments for COVID-19 and others.
CEO: Zhi HONG
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...